Lin Bo

Lin Bo serves as the President of T2 Systems since September 2024, following a notable tenure at Danaher Corporation from July 2015 to December 2023, where Lin held various leadership roles, including VP of Lean Transformation and Senior Director for APAC at Mammotome/Devicor Medical. In these roles, Lin steered lean transformation initiatives, achieved substantial year-over-year growth in APAC markets, and optimized sales performance in North America. Lin's previous experiences include leading global commercial operations at SCIEX, driving market research, and participating in strategic business development efforts at organizations such as BD and Infinity Pharmaceuticals. Lin holds an MBA from Harvard Business School and a BASc in Engineering from the University of Toronto.